Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan

BACKGROUND: Pyrazinamide (PZA) is an important first-line drug in multidrug-resistant tuberculosis (MDRTB) treatment. However, the unreliable results obtained from traditional susceptibility testing limits its usefulness in clinical settings. The detection of pncA gene mutations is a potential surro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Yu-Chi, Huang , Shiang-Fen, Yu, Kwok-Woon, Lee, Yu-Chin, Feng, Jia-Yih, Su, Wei-Juin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180675/
https://www.ncbi.nlm.nih.gov/pubmed/21910892
http://dx.doi.org/10.1186/1471-2334-11-240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180675/
https://www.ncbi.nlm.nih.gov/pubmed/21910892
http://dx.doi.org/10.1186/1471-2334-11-240

Ejemplares similares